Alkermes PLC

3 nov 2026, 23:01 UTC

Alkermes Plc is declining in after-market trading, retreating significantly from earlier gains.

2 nov 2026, 21:04 UTC

Alkermes initiates a phase 2 study for ALKS 7290 as an adjunctive therapy for major depressive disorder, amid broader market declines.

29 ott 2026, 20:06 UTC

Alkermes Plc shares are advancing, showing a modest gain since Wednesday's close and remaining notably above their 20-day moving average.

28 ott 2026, 20:52 UTC

Alkermes Plc shares are trading modestly lower in after-market hours, reflecting the broader market's significant decline amid recent economic data and the Fed's cautious outlook.

27 ott 2026, 19:46 UTC

Alkermes Plc shares fell modestly after retracing from an early high, though they remain above the 20-day moving average and near the upper end of their one-month range.

26 ott 2026, 19:46 UTC

Alkermes Plc is trading higher, showing strength above its 20-day moving average and near the upper end of its one-month range.

23 ott 2026, 20:07 UTC

Alkermes Plc shares fell amid a broader market decline, influenced by mixed economic indicators and rising oil prices raising inflation concerns.

22 ott 2026, 20:07 UTC

Alkermes Plc shares advanced, trading higher after Wednesday's close, despite pulling back from a session high earlier in the day.

21 ott 2026, 20:01 UTC

Alkermes Plc shares fell sharply after reaching an early high, declining to their lowest point before 3:30 PM.

20 ott 2026, 20:08 UTC

Alkermes Plc is trading higher, maintaining gains since Monday, despite pulling back from earlier session highs, and remains above its 20-day moving average.

19 ott 2026, 20:01 UTC

Piper Sandler reiterates Overweight rating on Alkermes and sets price target at $65 following management meetings.

17 ott 2026, 00:02 UTC

Alkermes Plc's shares advanced modestly in after-market trading on Friday, following three consecutive higher daily closes and a notable rise during the session.

16 ott 2026, 23:31 UTC

Alkermes Plc has advanced in after-market trading, reaching its highest level since Friday's close, continuing a stronger trend from recent sessions.

15 ott 2026, 20:01 UTC

Alkermes Plc shares are advancing, having gained since Wednesday's close, peaking nearly 4% earlier before pulling back slightly.

14 ott 2026, 20:07 UTC

Alkermes plans to present two oral presentations and six posters at the European Sleep Research Society’s Congress in October 2026.

12 ott 2026, 19:16 UTC

Alkermes Plc shares fell, continuing a trend of weakness, and are positioned below their 20-day moving average near the lower end of their one-month range.

9 ott 2026, 21:51 UTC

Alkermes Plc is declining in after-market trading, reaching its lowest point since Friday's close and remaining significantly below its 20-day moving average.

8 ott 2026, 20:01 UTC

Alkermes Plc shares fell, reversing a trend of higher daily closes amid a broader shift in market performance.

7 ott 2026, 19:25 UTC

Alkermes Plc shares fell modestly, retracing from a late morning high, contributing to a lower performance since Tuesday's close and remaining below the 20-day moving average.

6 ott 2026, 19:51 UTC

Alkermes Plc shares fell sharply, continuing a notable decline since Monday's close amid broader market conditions and trading below its 20-day moving average.

5 ott 2026, 23:40 UTC

Alkermes Plc is trading higher in after-market hours, extending its upward trend after three consecutive sessions of gains amid positive biotechnology sector performance.

2 ott 2026, 19:26 UTC

Alkermes Plc is trading sharply higher, recovering from earlier lows, despite remaining below its 20-day moving average and near the lower end of its one-month range.

1 ott 2026, 22:50 UTC

Alkermes Plc declined in after-market trading, moving lower since Thursday's close and positioning the stock below its 20-day moving average.

29 set 2026, 20:07 UTC

Alkermes Plc closed higher in Tuesday's trading session, despite notable volatility, finishing above Monday's close but below its 20-day moving average.

28 set 2026, 19:16 UTC

Alkermes Plc shares fell modestly, continuing a decline since Friday and trading near the lower end of their one-month range.

24 set 2026, 20:01 UTC

Alkermes Plc shares fell sharply as Goldman Sachs resumed coverage with a Neutral rating and a $50.00 price target, contributing to the stock's decline.

23 set 2026, 20:07 UTC

Alkermes Plc shares fell sharply today, hitting a midday low and remaining below the 20-day moving average after earlier strength in the session.

22 set 2026, 20:01 UTC

Alkermes Plc reported positive results from a phase 1 study for ALKS 7290, yet shares fell sharply, remaining below their 20-day moving average.

21 set 2026, 23:51 UTC

Alkermes Plc's stock is declining in after-market trading despite positive phase 1 results for ALKS 7290, remaining below its 20-day moving average.

18 set 2026, 20:02 UTC

Alkermes Plc shares fell sharply, reversing recent upward momentum, with a decline following a series of higher daily closes since Thursday's close.